Last reviewed · How we verify

NCT06220383

Evaluation of The Effect of Crowns Applied With Hall Technique on Occlusion

Completed NA Last updated 30 January 2024
What this trial tests

NA trial testing Hall technique in Child, Only in 78 participants. Completed in 20 December 2023.

Timeline
5 October 2022
Primary endpoint
12 October 2023
20 December 2023

Quick facts

Lead sponsorIzmir Katip Celebi University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment78
Start date5 October 2022
Primary completion12 October 2023
Estimated completion20 December 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Izmir Katip Celebi University

Who can join

Adults 5 to 8, any sex, with Child, Only or Quality of Life. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate and compare the change on occlusion after placing stainless steel crowns (SCC) using Hall technique and conventional technique in children between the ages of 5-8. In addition, the investigators planned to analyze the change in oral health-related quality of life between SCC applied with the Hall technique and SCC applied with the conventional method, before and after clinical application.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Hall technique

Trials testing the same drug.

Other recruiting trials for Child, Only

Currently open trials in the same condition.

Other Izmir Katip Celebi University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06220383.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing